PREMIER ASSET MANAGEMENT LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
PREMIER ASSET MANAGEMENT LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$336,00074,5150.06%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders